Over the past year, ImpactRx, a property of the private equity firm, Symphony Technology Group (Palo Alto, CA) acquired AlphaDetail and TargetRx, two companies involved with data and analytics on promotional effectiveness for the biopharma industry. Now, Symphony Technology has added Source Healthcare Analytics, a unit of Wolters Kluwer, to the mix, and is rebranding the entire group as Source Healthcare Analytics, LLC.
“Our strategic intent when we acquired ImpactRx a year ago was to build a differentiated solutions company in life sciences capable of delivering compelling value through insights informed by data,” said J.T. Treadwell, managing director at STG. “By taking this step, and building upon our earlier acquisitions of TargetRx and AlphaDetail, we have greatly accelerated our ability to deliver comprehensive value across a range of commercial decisions, and deliver patient centric insights at a unique scale.”
Source Healthcare Analytics (Phoenix, AZ) is a leading provider of information and analytics to the pharmaceutical, biotech and financial industries. The company’s brands include Source, ProMetis and inThought. A longstanding provider of market data and healthcare analytics, Source offers a unique set of comprehensive patient and physician-level prescribing and usage data. ProMetis provides a three-dimensional market view of prescriber, patient and payer activity. The inThought unit produces market research reports for global markets.
These four businesses will come together under Symphony Health Solutions. The current leaders of the businesses, Greg Ellis, president, ImpactRx; Bob Jansen, president, Source Commercial, and Michelle Woker, President Source Operations, will continue in their respective roles.
Wolters Kluwer had announced about a year ago that it would be divesting some of its healthcare informatics businesses, although it remains a player in analytics for healthcare providers and insurance companies. In 2005 it acquired NDC Health, which competed with SDI Health and IMS Health on collecting prescription sales data; now, with the merger of SDI Health and IMS that occurred at the beginning of this year, Symphony looks to be positioning itself competitively against IMS Health and others in this specialty.